Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Dörr, Jan Rafael (8) Fritsche, Raphaela Dr. (1) Henssen, Anton Prof. Dr. med. (1) Keller, Ulrich Dr. med. (1) Kempa, Stefan Dr. (1) Kirchner, Marieluise Dr. (1) Kirwan, Jennifer Dr. (1) Kunz, Severine Dr. (1) Mertins, Philipp Dr. (1) Rusu, Mara-Camelia Dr. (1) Scheidereit, Claus Prof. Dr. (1) Spanjaard, Bastiaan Dr. (1) Yu, Qinghao (1) (-) Schmitt, Clemens Prof. Dr. (7) 2010 (1) 2011 (1) 2013 (1) 2016 (1) 2018 (1) 2020 (1) 2024 (1) Advanced Light Microscopy (1) AG Schreiber [ECRC] (1) Bioinformatics and Omics Data Science (1) Biology of Malignant Lymphomas (3) Cancer Genetics and Cellular Stress Responses (89) Electron Microscopy (1) Genomics (1) Immune Dysregulations in Oncology (3) Mechanism-based Cancer Therapies (2) Microenvironmental Regulation in Autoimmunity and Cancer (1) Molecular Immunology and Gene Therapy (1) Proteomics (1) Proteomics and Metabolomics (1) RNA Biology and Posttranscriptional Regulation (1) Translational Oncology of Solid Tumors (2) (-) Tumor heterogeneity and treatment resistance in pediatric cancer (7) 7 Results: Active Filter: Schmitt, Clemens Prof. Dr.Tumor heterogeneity and treatment resistance in pediatric cancer Sort: Result score Newest to oldest Oldest to newest May 01, 2016 / Mol Cancer Ther CD20-targeting immunotherapy promotes cellular senescence in B-cell lymphoma J.H.M. Däbritz Y. Yu M. Milanovic M. Schönlein M.T. Rosenfeldt J.R. Dörr A.M. Kaufmann B. Dörken C.A. Schmitt July 20, 2020 / Nat Commun H3K9me3-mediated epigenetic regulation of senescence in mice predicts outcome of lymphoma patients K. Schleich J. Kase J.R. Dörr S. Trescher A. Bhattacharya Y. Yu E.M. Wailes D.N.Y. Fan P. Lohneis M. Milanovic A. Lau D. Lenze M. Hummel B. Chapuy U. Leser M. Reimann S. Lee C.A. Schmitt January 04, 2018 / Nature Senescence-associated reprogramming promotes cancer stemness M. Milanovic D.N.Y. Fan D. Belenki J.H.M. Däbritz Z. Zhao Y. Yu J.R. Dörr L. Dimitrova D. Lenze I.A. Monteiro Barbosa M.A. Mendoza-Parra T. Kanashova M. Metzner K. Pardon M. Reimann A. Trumpp B. Dörken J. Zuber H. Gronemeyer M. Hummel G. Dittmar S. Lee C.A. Schmitt March 01, 2024 / Cancer Discov Passenger gene coamplifications create collateral therapeutic vulnerabilities in cancer Y. Bei Luca Brame M. Kirchner R. Fritsche-Guenther S. Kunz A. Bhattacharya M.C. Rusu D. Gürgen F.P.B. Dubois J.K.C. Köppke J. Proba N. Wittstruck O.A. Sidorova R. Chamorro González H. Dorado Garcia L. Brückner R. Xu M. Giurgiu E. Rodriguez-Fos Q. Yu B. Spanjaard R.P, Koche C.A. Schmitt J.H. Schulte A. Eggert K. Haase J. Kirwan A.I. Hagemann P. Mertins J.R. Dörr A.G. Henssen March 16, 2010 / Canc Cell Tumor stroma-derived TGF-beta limits Myc-driven lymphomagenesis via Suv39h1-dependent senescence M. Reimann S. Lee C. Loddenkemper J.R. Dörr V. Tabor P. Aichele H. Stein B. Doerken T. Jenuwein C.A. Schmitt October 15, 2011 / Genes Dev Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations H. Jing J. Kase J.R. Dörr M. Milanovic D. Lenze M. Grau G. Beuster S. Ji M. Reimann P. Lenz M. Hummel B. Doerken G. Lenz C. Scheidereit C.A. Schmitt S. Lee September 19, 2013 / Nature Synthetic lethal metabolic targeting of cellular senescence in cancer therapy J.R. Dörr Y. Yu M. Milanovic G. Beuster C. Zasada J.H.M. Däbritz J. Lisec D. Lenze A. Gerhardt K. Schleicher S. Kratzat B. Purfürst S. Walenta W. Mueller-Klieser M. Gräler M. Hummel U. Keller A.K. Buck B. Dörken L. Willmitzer M. Reimann S. Kempa S. Lee C.A. Schmitt
May 01, 2016 / Mol Cancer Ther CD20-targeting immunotherapy promotes cellular senescence in B-cell lymphoma J.H.M. Däbritz Y. Yu M. Milanovic M. Schönlein M.T. Rosenfeldt J.R. Dörr A.M. Kaufmann B. Dörken C.A. Schmitt
July 20, 2020 / Nat Commun H3K9me3-mediated epigenetic regulation of senescence in mice predicts outcome of lymphoma patients K. Schleich J. Kase J.R. Dörr S. Trescher A. Bhattacharya Y. Yu E.M. Wailes D.N.Y. Fan P. Lohneis M. Milanovic A. Lau D. Lenze M. Hummel B. Chapuy U. Leser M. Reimann S. Lee C.A. Schmitt
January 04, 2018 / Nature Senescence-associated reprogramming promotes cancer stemness M. Milanovic D.N.Y. Fan D. Belenki J.H.M. Däbritz Z. Zhao Y. Yu J.R. Dörr L. Dimitrova D. Lenze I.A. Monteiro Barbosa M.A. Mendoza-Parra T. Kanashova M. Metzner K. Pardon M. Reimann A. Trumpp B. Dörken J. Zuber H. Gronemeyer M. Hummel G. Dittmar S. Lee C.A. Schmitt
March 01, 2024 / Cancer Discov Passenger gene coamplifications create collateral therapeutic vulnerabilities in cancer Y. Bei Luca Brame M. Kirchner R. Fritsche-Guenther S. Kunz A. Bhattacharya M.C. Rusu D. Gürgen F.P.B. Dubois J.K.C. Köppke J. Proba N. Wittstruck O.A. Sidorova R. Chamorro González H. Dorado Garcia L. Brückner R. Xu M. Giurgiu E. Rodriguez-Fos Q. Yu B. Spanjaard R.P, Koche C.A. Schmitt J.H. Schulte A. Eggert K. Haase J. Kirwan A.I. Hagemann P. Mertins J.R. Dörr A.G. Henssen
March 16, 2010 / Canc Cell Tumor stroma-derived TGF-beta limits Myc-driven lymphomagenesis via Suv39h1-dependent senescence M. Reimann S. Lee C. Loddenkemper J.R. Dörr V. Tabor P. Aichele H. Stein B. Doerken T. Jenuwein C.A. Schmitt
October 15, 2011 / Genes Dev Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations H. Jing J. Kase J.R. Dörr M. Milanovic D. Lenze M. Grau G. Beuster S. Ji M. Reimann P. Lenz M. Hummel B. Doerken G. Lenz C. Scheidereit C.A. Schmitt S. Lee
September 19, 2013 / Nature Synthetic lethal metabolic targeting of cellular senescence in cancer therapy J.R. Dörr Y. Yu M. Milanovic G. Beuster C. Zasada J.H.M. Däbritz J. Lisec D. Lenze A. Gerhardt K. Schleicher S. Kratzat B. Purfürst S. Walenta W. Mueller-Klieser M. Gräler M. Hummel U. Keller A.K. Buck B. Dörken L. Willmitzer M. Reimann S. Kempa S. Lee C.A. Schmitt